Patents Assigned to GlycanAge LTD
  • Publication number: 20240044917
    Abstract: The present disclosure reveals the diagnostic method for the determination of multiday average molar concentration of estradiol (E2) and from this parameter, the assessment of perimenopause and menopause status in examined female subjects, based on quantitative analysis of N-glycans bound on immunoglobulin G (IgG). The diagnostic process is applicable to the female subjects of 40-55 years of age. The revealed method enables the determination of the multiday average molar concentration of estradiol (E2), which is an important diagnostic parameter hardly accessible by any known single diagnostic method applied on only one or more blood analyses.
    Type: Application
    Filed: September 27, 2023
    Publication date: February 8, 2024
    Applicants: GENOS d.o.o., GlycanAge LTD
    Inventors: Gordan LAUC, Cristina MENNI, Domagoj KIFER, Nikolina LAUC